Avalanche (AVAX) price held steady at $8.85 today, as cautious buyers entered the market amid weekly losses of 11.82%. The token’s 24-hour trading volume increasedAvalanche (AVAX) price held steady at $8.85 today, as cautious buyers entered the market amid weekly losses of 11.82%. The token’s 24-hour trading volume increased

Will AVAX Hit $10.5? Price Holds $8.85 Amid Oversold Market

2026/02/10 20:45
3 min read

Avalanche (AVAX) price held steady at $8.85 today, as cautious buyers entered the market amid weekly losses of 11.82%. The token’s 24-hour trading volume increased slightly to $241.22 million, signaling growing market participation, as per the CoinMarketCap data.

Analysts note that while the market shows early signs of consolidation, broader macro pressures continue to weigh on altcoin momentum.

The token’s market capitalization stands at $3.82 billion, remaining relatively stable over the same period. Technical indicators suggest oversold conditions, which could support a short-term relief bounce if buying momentum persists.

Also Read: Avalanche (AVAX) Plummets to $9, Eyes $8.35 Support Next

Key Price Levels and Long-Term Trend

According to the crypto analyst K A L E O, AVAX remains in a long-term downtrend, forming lower highs while revisiting key support at $3.0–$3.6. Sharp capitulation wicks triggered rebounds toward $4.5, stabilizing the broader structure.

Temporary volatility spikes occurred, but macro pressure remains, shaping medium-term price expectations globally. The current recovery has a higher low and is headed towards the lower trend line of resistance. If it breaks out, the prices may go to $5.4-$6.3 and then to $7.2-$9.0.

If the buying pressure continues and more spot and derivatives market participants join the buying, the price may reach $10.5, indicating a possible trend reversal in the medium term.

Source: @CryptoKaleo

A rejection at the trend line may cause AVAX to decline to $4.5, with the price testing the support levels of $3.0 to $3.6 once again. If it breaches this level, it may continue to decline before attempting to move back up to $5.4-$6.3, $7.2-$9.0, and eventually $10.5.

Strong Selling Pressure Detected in Market

As per the TradingView chart, the Relative Strength Index (RSI) is at 30.15, which is close to the oversold level of 30. This indicates that there has been strong selling pressure in the recent past.

The oversold market may see a bounce, but the RSI is still showing weak momentum with no sign of reversal. One needs to see if there is buying pressure that can move the momentum above the threshold.

Source: TradingView

MACD remains bearish, with the MACD line at -1.03813, the signal line at -0.94655, and the histogram at -0.09158. The decreasing histogram indicates that the momentum of the bearish market is decreasing, which indicates a possible consolidation or relief rally. When combined with the RSI indicators, it indicates that the market is trading under cautious conditions.

Why This Matters

Understanding the $3.0-$3.6 support and $5.4-$6.3 resistance levels helps traders determine entry and exit points, while helping form risk management strategies in the face of AVAX’s spicy volatility.

Identifying oversold levels and the $7.2-$9.0 breakout level helps investors anticipate relief rallies or trend reversals.

Also Read: Avalanche AVAX Plummets to $8.94: Could Fall to $4–$6 Next

Market Opportunity
Avalanche Logo
Avalanche Price(AVAX)
$8.6
$8.6$8.6
-2.09%
USD
Avalanche (AVAX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.